Efficacy and tolerability of myrtol standardized in long-term treatment of chronic bronchitis A double-blind, placebo-controlled study Study Group Investigators.

De Mey and Riechelmann conducted a multicenter, randomized, double-blind, placebo-controlled clinical trial where Myrtol® standardized (GeloMyrtol® forte) was tested against placebo in patients with chronic sinusitis for a time period of 3 months. This review intends to give an insight into several prescription indications of Myrtol ® standardized, all involved mechanisms, and potential advantages toward antibiotic therapy, especially in cases when bacterial infection is uncertain. Suchen Sie Ihren Arzt auf, wenn zusätzlich Beschwerden wie Atemnot, Fieber, eitriger oder blutiger Auswurf auftreten. Da der Arzt sie individuell abstimmt, sollten Sie das Arzneimittel daher nach seinen Anweisungen anwenden. The alveolar macrophages were precultured with essential oils (Myrtol, eucalyptus oil, and orange oil) for 1 h and then stimulated with lipopolysaccharide (LPS) (1 µg/ml).Der therapeutische Nutzen kann höher sein, als das Risiko, das die Anwendung bei einer Gegenanzeige in sich birgt. Ninety-eight patients with AECOPD were randomly divided into a group treated with 300 mg three times daily Myrtol® standardized and a control group while all patients received the conventional treatment.

However, there is one case reported in the literature, where anaphylactic shock was developed after receiving a GeloMyrtol® forte capsule to treat an upper respiratory system infection. However, the administration of Myrtol® standardized significantly attenuated the MUC5AC hypersecretion and reduced the production of IL-6 and TNF-alpha in the PA infected lungs, indicating a secretolytic and anti-inflammatory effects.

The reduction of TNF-alpha was only an early effect, which could not be further stimulated, and the reduction of IL-8 was inconsiderably. investigated the ability of essential oils to reduce cytokines release and production of ROS derived from ex vivo cultured alveolar macrophages taken from patients with COPD, GOLD Stadium III–IV. Symptoms such as convulsive cough and pressure headache are relieved, and the nasal congestion is cleared. Es gibt nach derzeitigen Erkenntnissen keine Hinweise darauf, dass das Arzneimittel während der Stillzeit nicht angewendet werden darf.